Home Blend Therapeutics Appoints Drew Fromkin as President and Chief Executive Officer
 

Keywords :   


Blend Therapeutics Appoints Drew Fromkin as President and Chief Executive Officer

2015-04-13 16:44:27| Biotech - Topix.net

Blend Therapeutics, Inc. , a biopharmaceutical company discovering and developing two distinct classes of targeted anti-cancer medicines to advance the treatment of patients with solid tumor cancers, announced today the appointment of Drew Fromkin as President and Chief Executive Officer and a member of the company's Board of Directors. Mr. Fromkin previously served as President and Chief Executive Officer of Clinical Data, Inc., until its acquisition by Forest Laboratories.

Tags: executive president chief officer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.11dura ace 32H
25.11 (S)
25.111592 33mm 33mm
25.11 DVD 7
25.11DR4270
25.11A +A act2
25.115 SEED FREEDOM
25.11
More »